Cryo-Cell International, Inc. (CCEL)

Cryo-Cell International Balance Sheet

Financials in millions USD. Fiscal year is December - November.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Cash & Equivalents	0.51	0.32	0.56	0.41	1.7	8.26
Short-Term Investments	2.65	2.98	2.94	0.57	0.02	0.08
Cash & Short-Term Investments	3.16	3.3	3.5	0.98	1.72	8.34
Cash Growth	-28.64%	-5.72%	256.66%	-43.06%	-79.35%	-20.20%
Accounts Receivable	6.91	6.85	7.31	6.58	6.04	5.25
Inventory	0.31	0.41	0.66	0.77	0.85	0.92
Other Current Assets	0.92	1.21	1.09	1.13	0.99	1.27
Total Current Assets	11.3	11.76	12.55	9.45	9.61	15.78
Net Property, Plant & Equipment	21.29	21.85	22.7	22.03	14.21	4.15
Other Intangible Assets	0.84	0.86	0.92	0.99	15.15	16.19
Goodwill	1.94	1.94	1.94	1.94	1.94	12.01
Long-Term Investments	-	-	-	0.31	0.31	0.31
Other Long-Term Assets	25.33	24.54	22.39	26.5	23.66	12.22
Total Assets	60.71	61.73	64.68	61.22	64.89	60.66

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Accounts Payable	2.85	2.87	1.88	3.17	1.61	1.49
Accrued Expenses	2.97	4.28	5.81	5.17	3.59	3.06
Short-Term Debt	-	2.3	3.52	1.22	2.27	-
Current Portion of Long-Term Debt	0.2	0.18	0.17	0.17	0.15	1.9
Current Portion of Leases	0.42	0.43	0.43	0.23	0.3	0.31
Unearned Revenue	9.5	9.73	9.79	9.7	9.59	9.36
Other Current Liabilities	-	-	-	1.2	1.98	4.96
Total Current Liabilities	15.93	19.79	21.6	20.86	19.48	21.07
Long-Term Debt	8.08	8.17	8.31	8.43	8.58	-
Long-Term Leases	0.26	0.47	0.51	0.85	0.31	0.61
Other Long-Term Liabilities	54.19	51.9	47.48	42.11	38.04	34.79
Total Long-Term Liabilities	62.53	60.54	56.29	51.39	46.93	35.4
Total Liabilities	78.46	80.33	77.89	72.25	66.41	56.48

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Common Stock	0.15	0.15	0.15	0.15	0.15	0.15
Treasury Stock	-25.03	-25.03	-24.86	-23.43	-22.63	-20.81
Additional Paid-in Capital	44.96	44.71	44.27	43.41	42.6	41.59
Retained Earnings	-37.84	-38.44	-32.78	-31.16	-21.64	-16.74
Shareholders' Equity	-17.76	-18.61	-13.22	-11.03	-1.52	4.18
Total Liabilities & Equity	60.71	61.73	64.68	61.22	64.89	60.66

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Total Debt	8.96	11.56	12.93	10.9	11.61	2.82
Net Cash (Debt)	-5.8	-8.26	-9.44	-9.92	-9.89	5.52
Net Cash Growth	-	-	-	-	-	31.08%
Net Cash Per Share	-0.72	-1.02	-1.15	-1.19	-1.17	0.66
Book Value	-17.76	-18.61	-13.22	-11.03	-1.52	4.18
Book Value Per Share	-2.20	-2.31	-1.61	-1.32	-0.18	0.50
Tangible Book Value	-20.54	-21.41	-16.08	-13.96	-18.62	-24.02
Tangible Book Value Per Share	-2.55	-2.65	-1.96	-1.67	-2.19	-2.87

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Jul 15, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 26, 2026

Data Sources Report a data error